Sharing is caring!
Get Social with Anand Spine Group

Join us on Facebook


@InfoSpine
& @ScoliosisDoctor


Visit Dr. Anand's SpineUniverse Blog for spine surgery advice and his thoughts on the latest news in spine health.

Share our site!
Bookmark and Share

 

Welcome to Infospine of Los Angeles, CA. - The Anand Spine Group

Infospine.net is the official online resource for information about innovative spine treatments performed by The Anand Spine Group surgeons; Dr. Neel Anand and Dr. Eli M. Baron.

Dr. Anand and Dr. Baron are on staff in Los Angeles, California at the Cedars-Sinai Medical Center, Spine Center.

The Anand Spine Group's primary area of research interest involves minimally invasive surgical techniques for spinal disorders and trauma in adults and children, which result in smaller incisions, faster recovery and better patient outcomes. Recently Dr. Anand has pioneered the utilization of three minimally invasive techniques to treat even the most complex of spinal deformity and scoliosis.

The Anand Spine Group is also active in the development of new non-fusion, motion preservation techniques including Cervical Artificial Disc Replacements (NeoDisc, PCM, ProDisc), Posterior Non-Fusion Stabilization Systems (Stabilimax NZ, Dynesys, DIAM, Acadia Facet Replacement System ), and Lumbar Artificial Disc Replacements (ProDisc, In Motion).

Latest News

Dr. Anand on NFL Network Explaining Peyton Manning’s Neck Injury & recovery from Surgery

Dr. Anand on ABC7 News Scoliosis Screening

Dr. Anand on ABC7 News Straightening Spines & Shortening Recoveries

Dr. Anand on ABC7 News Sacroiliac Low Back Pain Treated with IFuse Implant

Dr. Anand on KCAL9 News Dynseys Spine Treatment

Dr. Anand on NBC4 News Dynseys Spine Treatment

RADIO INFOSPINE NEWS

Radio Interview on:

Radio Interview Podcast - Dr. Neel Anand discusses "New Clinical Trial Offers Hope to Back Patients"

Topic Info:

Dr. Neel Anand, Director of Orthopaedic Spine Surgery and Director of Minimally Invasive Spine Surgery at the world famous Cedars Sinai Hospital in Los Angeles joins the show to discuss new options, including clinical trials for relieving Spinal Stenosis.

Radio Interview: Effectiveness of Teens Wearing Back Braces to Avoid Spine Surgery Later in Life.

Radio Interview: Effectiveness of Teens Wearing Back Braces to Avoid Spine Surgery Later in Life.  Dr. Neel Anand, orthopedic spine surgeon at the Cedars-Sinai Spine Center, explains the benefits of wearing a back brace.

Effectiveness of Teens Wearing Back Braces to Avoid Spine Surgery Later in Life (mp3)

WFAN Sports Radio: In this CBS Sports Radio interview, Dr. Anand discusses prognosis for NY Giants’ DE Jason Pierre-Paul after undergoing spine surgery.

Jason Pierre-Paul undergoes back surgery. (mp3)

Dr. Anand Radio Interview Podcasts - 4 part series!

Listen to all 4 parts of the radio interview on "New Clinical Trial Offers Hope to Back Patients" to the left.

You can also download each podcast to your favorite audio player below.

Clinical Trials - What Are They? (mp3)
What You Should Know Before Participating in a Clinical Trial (mp3)
How to Find Clinical Trials (mp3)
Are You a Good Candidate for a Clinical Trial? (with patient) (mp3)

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

KFI AM 640 Radio Interview

Dr. Anand discusses ways to reduce back pain at your desk job.

Download the MP3 of this Podcast to your phone or favorite mp3 player (mp3)

PRINT MEDIA INFOSPINE NEWS

Article

Dr. Anand discusses minimally-invasive spinal deformity correction in this May 2012 edition of the European Spine Journal. Click here to read full article

Article

Dr. Neel Anand, Director of Orthopaedic Spine Surgery at the Cedars-Sinai Spine Center in Los Angeles, would be happy if orthopedists would just examine their patients. Click here to read full article




The Scoliosis Association, Inc., An International Information and Support Network

Minimally Invasive Correction of Adult Degenerative Scoliosis

Download BackTalk January 2010 Issue

Dr. Anand featured in LA Times June 1, 2009 - A Less Invasive Scoliosis Remedy

Research Trials

THE ANAND SPINE GROUP SELECTED TO STUDY USE OF CARTILAGE CELLS THAT MAY REGENERATE SPINAL DISCS

CONTACT: Trace Longo
Longo Communications
(949) 364-2821

Nationwide Phase II Clinical Trial Examines NuQu®: An Investigational Novel Cell-based Therapy for Painful Spinal Discs

LOS ANGELES, Calif. – The Anand Spine Group in Los Angeles has received approval to participate in a Phase II clinical trial, sponsored by St. Louis, MO-based ISTO Technologies, Inc., studying the use of cartilage cells that may help regenerate spinal discs.

The Anand Spine Group, lead by orthopaedic spine surgeon and medical director Dr. Neel Anand, is one of a select group of spine centers throughout the U.S. taking part in the study to evaluate the efficacy and safety of ISTO’s NuQu® cell-based therapy. NuQu® is comprised of young cartilage cells that are delivered through a needle during a short, one-time procedure performed by Dr. Anand. Study participants may go home about one hour after the procedure.

“We are very excited to be selected as investigators in the NuQu® study because it offers a unique opportunity for volunteers who meet the study’s criteria to potentially participate in research for low back pain and disability caused by spinal disc disease,” said Dr. Anand.

ISTO estimates that each year in the U.S. there are approximately 500,000 patients presenting with discogenic back pain who do not respond to standard-of-care treatment. This significant group of pain sufferers, who either refuse or are not medical candidates for surgery, represents a chronically disabled population of potential study volunteers. There are currently no FDA approved disc nucleus regeneration or repair products on the market.

The economic and social impact of back pain places a tremendous burden on patients suffering from the condition, as well as on the U.S. healthcare system and overall economy. It is estimated that, on average, 297 million restricted workdays and 87 million disability days are lost each year due to back pain, the leading source of which is intervertebral disc disease or degeneration. In a study released in 2004 mined from data from the Medical Expenditure Panel Survey, Duke University Medical Center researchers found that patients in the U.S. suffering from back pain consume more than $90 billion annually in health-care expenses, with approximately $26 billion of that amount directly attributable to the treatment of back pain.

“There are countless numbers of people suffering from debilitating low back pain caused by degenerated discs that must either manage the pain through physical therapy and injections or undergo surgery,” added Dr. Anand. “We hope that this study will provide us the scientific data needed to support the continued use of this investigational technology.”

Study participants must have had low back pain for at least six months and have never had previous surgery on their lower back. NuQu® is not recommended for smokers or women who are pregnant or currently breastfeeding. Patients can learn more about the NuQu® study at The Anand Spine Group by contacting Dr. Anand’s clinical coordinator Cece Bruce at (310) 423-9209.

Learn more about clinical trials in this 4 part podcast radio interview with Dr. Anand. Topics include:

Dr. Neel Anand commences participation in FDA pivotal clinical trial of Stabilimax NZ Dynamic Spine Stabilization System

You might be eligible to participate in a clinical research study for the treatment of spinal stenosis. Dr. Neel Anand at Cedars-Sinai Medical Center - Spine Center is conducting a study to compare the safety and effectiveness of the Stabilization NZ Dynamic Spine Stabilization System to spine fusion. Download NZ Stabilization Study PDF

  • The Anand Spine Group is involved in several Research Trials. If you are interested in learning more please contact us online or by calling 310-423-9779.
  • Acadia Facet Replacement System – a total joint replacement for the facets. This is used to treat spondylolisthesis and stenosis.
  • Stabilimax NZ Dymnamic Stabilization System – Preserve your motion while treating degenerative stenosis.
  • Neodisc Cervical Artificial Disk – Enrollment complete
  • Click here to learn more about our current clinical trials
Radio Interview on:


Radio Interview Podcast - Dr. Neel Anand discusses "New Clinical Trial Offers Hope to Back Patients"

Topic Info:
Dr. Neel Anand, Director of Orthopaedic Spine Surgery and Director of Minimally Invasive Spine Surgery at the world famous Cedars Sinai Hospital in Los Angeles joins the show to discuss new options, including clinical trials for relieving Spinal Stenosis.

Dr. Anand Radio Interview Podcasts - 4 part series!

Listen to all 4 parts of the radio interview on "New Clinical Trial Offers Hope to Back Patients" to the left.

You can also download each podcast to your favorite audio player below.

Clinical Trials - What Are They? (mp3)
What You Should Know Before Participating in a Clinical Trial (mp3)
How to Find Clinical Trials (mp3)
Are You a Good Candidate for a Clinical Trial? (with patient) (mp3)

News Releases

Long-Term Study Proves Minimally Invasive Surgery Effective for Correcting Spinal Deformities

CONTACT: Trace Longo
Longo Communications
(949) 364-2821

LOS ANGELES, Calif. – An estimated six million people in the United States have some form of scoliosis, a condition in which the curves of the spine are abnormal, causing strain on the body. Among the most common myths about scoliosis and other spinal deformities is that surgery to correct them is extremely invasive and painful, or that they cannot be corrected with surgery at all.

The results from a new long-term study published in the August 15, 2013 issue of the journal Spine show that minimally invasive surgery (MIS) is effective for the long-term correction of spinal deformities, including adult scoliosis. Spearheaded by Neel Anand, M.D., clinical professor of surgery and director of spine trauma at Cedars-Sinai Spine Center in Los Angeles, the study evaluates the overall efficacy of MIS, compared to open lumbar fusion, over two to five years and finds that a combination of three novel MIS techniques provides correction of adult spinal deformity comparable to traditional “open” surgery, but with significantly improved functional outcomes, excellent clinical and radiological improvement, and enhanced recovery times because of reduced blood loss and complication rates at early and long term follow-up.

“This is a concept we pioneered nearly 10 years ago and now we have the clinical data to demonstrate the positive long-term results of minimally invasive strategies for the correction of spinal deformities,” says Dr. Anand. “This study is especially significant for our country’s aging population in which many suffer from degenerative scoliosis. The minimally invasive techniques make it feasible for them to have their condition corrected, which otherwise would have been too invasive and painful using traditional methods.”

Over the two to five-year period, Dr. Anand and co-investigators reviewed 71 patients between the ages of 20-84 who underwent MIS correction of spinal deformity with fusion of two or more levels including degenerative scoliosis (54), idiopathic scoliosis (11), and iatrogenic scoliosis (6). All patients underwent a combination of three MIS techniques including segmental multi-level percutaneous pedicle screw fixation (posterior instrumentation) (67), direct lateral interbody fusion (DLIF) (66), and axial lumbar interbody fusion (AxiaLIF) (34). Thirty-six patients were staged with DLIF performed first followed by the posterior instrumentation and fusion including AxiaLIF done three days later.

Patients with one-stage same day surgery (<3 levels) had a mean blood loss of 412 ml and a mean surgical time of 291 minutes. Patients with two-stage surgery (>4 levels) had a mean blood loss of 314 ml and surgical time of 183 minutes for DLIF and 357 ml and 243 minutes respectively for posterior instrumentation and AxiaLIF. The mean hospital stay was 7.6 days including the three days between stages. As a result, blood loss and surgical complications were considerably less than those associated with more traditional open deformity correction procedures. At long term follow-up there was also a significant improvement in all functional and disability domains.

“This is the first study documenting the long term results of minimally invasive correction techniques for spinal deformity and it represents a paradigm shift in the way scoliosis can be effectively treated,” adds Dr. Anand.

Neel Anand, MD, Mch Orth, Eli M. Baron, MD, Babak Khandehroo, MD, and Sheila Kahwaty, PA-C. Long-term 2- to 5-Year Clinical and Functional Outcomes of Minimally Invasive Surgery for Adult Scoliosis. Spine, Volume 38, Number 00, August 00, 2013.

 

 

THE ANAND SPINE GROUP SELECTED TO STUDY FACET JOINT REPLACEMENT SURGERY

Clinical Trial Studies Facet Joint Replacement Surgery Utilizing the Investigational ACADIA™ Facet Replacement System to Treat Lumbar Spinal Stenosis

CONTACT: Trace Longo
Longo Communications
(949) 364-2821

The Anand Spine Group in Los Angeles has received approval to participate in a clinical trial that may redefine surgery for low back and leg pain. The study, which will be led by Dr. Neel Anand, orthopedic spine surgeon and medical director of The Anand Spine Group, focuses on a new concept in spine surgery called Facet Joint Replacement. The Anand Spine Group is one of a select group of spine centers throughout the U.S. taking part in the landmark IDE study.

“We are very excited to be selected as investigators in the Facet Replacement study because it offers a unique opportunity for our patients who meet the study’s criteria to participate in cutting-edge research for lower back and leg pain,” said Dr. Anand.

The Facet Joint Replacement (FJR) study surgery utilizes investigational artificial facet joints called the ACADIA Facet Replacement System that is designed to help recreate the motion and function of healthy facet joints. These artificial facet joints are designed to provide stability to the spine without the potential loss of motion associated with spinal fusion and to enable vertebrae to move naturally in relation to one another.

“Just like knee and hip replacements, Facet Joint Replacement surgery has the potential to eliminate pain without eliminating the body’s natural range of motion,” said Dr. Anand. “We believe this new surgery could be a safer and more effective alternative to conventional spinal fusion.”

Approximately 1.2 million U.S. adults suffer from lumbar spinal stenosis, a condition in which the spinal canal narrows which can cause nerve compression and irritation. This can lead to debilitating pain, tingling, or numbness in the lower back and legs. Each year, hundreds of thousands of patients undergo surgery to treat chronic back and leg pain due to lumbar spinal stenosis. Conventional surgery for this condition involves the permanent fusing together of spine bones and joints to stabilize the spine. While effective, this also eliminates natural motion between these bones, and may cause surrounding spine bones to take on added stress, leading to further spine degeneration.

The IDE study is sponsored by Globus Medical, Inc. Study participants must be between the ages of 21 and 85 with a history of low back and leg pain. Patients can learn more about the ACADIA™ Facet Replacement System IDE study at The Anand Spine Group by contacting Dr. Anand’s clinical coordinator Cece Bruce at (310) 423-9209.

 

 

The Anand Spine Group Now Offering Patients New iFuse Implant System For Treatment of Sacroiliac Joint Problems

CONTACT: Trace Longo
Longo Communications
(949) 364-2821

The Anand Spine Group in Los Angeles recently announced that it is now offering patients with sacroiliac (SI) joint disruptions and degenerative sacroiliitis, a new minimally invasive spine surgery using the iFuse Implant System.

“We are very excited to offer the iFuse Implant System to our patients because it offers them a clinically proven solution for an often undiagnosed and mistreated condition,” said Dr. Neel Anand, orthopedic spine surgeon and medical director of The Anand Spine Group.

The iFuse Implant System, developed by San Jose, CA-based SI-BONE, Inc., is a commercially available device in the U.S. that is intended for the fixation of large bones and large bone fragments of the pelvis for SI joint maladies. iFuse is a minimally invasive surgical procedure for the delivery and implantation of small, titanium implants. The implants are coated with a porous plasma spray that acts as an interference surface, designed to help decrease implant motion. These implants also have substantial thickness and sophisticated metallurgy and are able to produce a much stronger construct than that of conventional pins or screws used to surgically fix boney structures.

The iFuse Implant System offers the following benefits for patients:

- Less invasive than traditional open surgery with no extensive soft tissue stripping
- Straightforward minimally invasive surgical approach
- Rigid titanium implants provide immediate post-op SI joint stability
- Porous plasma spray coating with irregular surface designed to support stable bone fixation/fusion
- Biomechanically rigorous implant designed specifically to stabilize the heavily loaded SI joint
- Recovery is on average 2 weeks as opposed to 6 months.

“We believe this new implant system will improve surgical outcomes and reduce recovery times by more than five months because of its minimally invasive surgical approach and biomechanical design,” added Dr. Anand.

According to studies, more than 22% of individuals who presented with lower back complaints actually had problems in their SI joint. There are approximately one million patients annually with low back complaints that have SI joint problems like degenerative arthritis and/or mal-unions of pelvic trauma. Additional studies show that nearly 25% of all low back pain is sacroiliac joint in origin and that the diagnosis of sacroiliac joint disease is frequently overlooked by physicians.

SI joint problems often mimic discogenic or radicular low back pain. Many low back pain patients go on to receive lumbar fusion surgery instead of sacroiliac joint fixation/fusion. As a result, sacroiliac joint disease is becoming for frequently considered in differential diagnosis of low back pain. A recent study shows that the incidence of SI joint degeneration in post-lumbar fusion surgery is 75% at 5 years post surgery.
Despite the large number of patients with SI joint symptoms, most of the treatment focus in the spine is centered on the disc. Orthopedic residents and neurosurgical residents are rarely taught to consider SI joint arthritis and/or old trauma as the cause of the patient’s problems. In addition, few, if any, lumbar MRI’s extend below S1 to examine the sacroiliac SI joint.

For more information about the iFuse Implant System or to schedule an appointment, please call The Anand Spine Group at (310) 423-9209.



Minimally Invasive Surgery
Microdiscectomy
Fusion

Motion Preservation
Dynamic Stabilization
Artificial Disc

Scoliosis Surgery
MIS Scoliosis Surgery

 

Deformities
Degenerative Disorders
Spinal Injury